Weekly Twitter Roundup
Posted by Dan Vorhaus on March 19, 2010
Each week there are a number of stories and developments that, for one reason or another, don’t find their way into a full-length posting on the Genomics Law Report. Here’s a recap of what I was Tweeting this week @genomicslawyer:
- Well-designed genomics career resource from NHGRI: http://bit.ly/buhcbs Something for everybody on there. HT @GenomeWeb_News
- NIH Foundation, Biomarkers Consortium Team on Breast Cancer Trials: http://bit.ly/co1ZPq v @GenomeWeb_News
- Top Genomics Journalists: http://bit.ly/9LWjmR v @AccessDNA | Agree w/ entire list: @markgfh @tgoetz @emilysinger @matthewherper @Duncande
- RT @PGorg: PGP-100 enrollment starting now! And other news items: http://www.personalgenomes.org/newsletter/03.html
- Genomics Law Report: Evaluating the NIH’s New Genetic Testing Registry: http://bit.ly/a4NmCt
- A Personalized Critique of Comparative Effectiveness Misses the Mark: http://bit.ly/bUB9bD (from @crossborderbio)
- RT @EdwardWinstead: RT @NIHforHealth: News: NIH Announces Genetic Testing Registry http://bit.ly/alUJ5C
- Regulations, Clinical Utility & Personal Genetics: http://bit.ly/dmUnI2
- RT @FierceBiotech: Roche/Genentech try to develop companion diagnostic tests for all their experimental drugs. #RocheIR
- Hank Greely on the coming “Explosion of Prenatal Genetic Testing”: http://bit.ly/afzAVF (HT @GenCounsNews) Also: http://bit.ly/1nfDwM
- RT @MishaAngrist: Nobel Symposium: GENETICS IN MEDICINE June 15 – 18, 2010 lots of heavy hitters: http://bit.ly/a8xdzq
- Watch @RebeccaSkloot on #Colbert talking #HeLa http://bit.ly/crXEWq (at 15:40) Great interview; handles Colbert’s questions better than most
- Genetic Health Report Now Available from @PathwayGenomics http://cot.ag/aky1OH (v @Berci, @blaine_5)
- Headline should read “not cost-effective” instead of “not clinically useful”: Genetic Testing vs. Gail for Cancer Risk: http://bit.ly/dpU3kD
- RT @dgmacarthur: RT @ilanafish: ABC radio: Dr Caroline Wright on non-invasive prenatal diagnosis http://bit.ly/bSl7bi
- RT @bmahersciwriter: Fingerprints, DNA & fMRI, Oh my. Nature’s “Science in Court” special is live: http://bit.ly/9o55gO
- RT @ldtimmerman: VCs on politics: Officials who say they love biotech innovation are actually suffocating it. http://bit.ly/cFXyCP
- Nice interview by @humangenomeorg with @MishaAngrist. Reminds us that personal genomics is *personal*: http://bit.ly/cDVKDQ
- More on Myriad/BRCA patent dispute from @Duncande. Nice to see attempts at solutions other than ban/status quo http://bit.ly/adO2WY
- Canada moves forward with biosimilars, even as the US remains stalled: http://bit.ly/ayhFLp (via @crossborderbio)
- Consent, Privacy & Research Biobanks in Canada. Well-written policy brief: http://bit.ly/984s9z (HT @mikesgene)
- Duke researchers investigate “surprising breadth” of Myriad BRCA patent claim: http://bit.ly/c8diOr (HT @DukeIGSP)
- RT @dgmacarthur: Carrier testing company @counsyl has now raised almost $5M in venture capital: http://j.mp/9GClF8
- RT @wilbanks: RT @gkjohn: ‘Open’ Vs. ‘Public’ Data — The Big Difference http://ff.im/-hEq3m
- RT @ldtimmerman: Biotech maven Steve Burrill on how the IPO mkt still lousy, and how Dx will beat Rx in future. http://bit.ly/909GGr
- Free, yes. Payment creates ELSI issues. re: Stan Nelson’s comment – companies may pay you to be sequenced (@dgmacarthur @bioitworld) #XGen
- What the FCC’s Broadband Report Means for Genomics and Personalized Medicine: http://bit.ly/bfybKm
- Presage Raises $3M on strength of new model for predicting which cancer drugs will succeed: http://bit.ly/aNi7Cb (by @ldtimmerman)
- Drugs Are For Sick People: http://cptl.st/aPPMuK by @matthewherper
- RT @crossborderbio, @JohnCFierce: VC funding for life sciences $1.9B in 4Q, flat from 3Q, but biotech VC rounds swell. http://bit.ly/9Q5jOZ
- MedCo/Mayo study continues to press the case for genetic testing in Warfarin prescribing: http://bit.ly/d3wKmM (HT @tgoetz)
- Long’s Op-Ed on Personal Genomics Comes Up Short: http://bit.ly/clB4E3
- The Texas Newborn Bloodspot Saga has Reached a Sad – and Preventable – Conclusion http://bit.ly/cbI8he
- GPPC DTC genetic test list (last tweet) is helpful, but far greater specificity w/r/t price, SNPs tested, quality of testing, etc. needed.
- Genetics & Public Policy Center updates its DTC genetic testing lists by both company & disease: http://bit.ly/8YKYv5
- RT @Scitable: Human Egg To Be Raffled Off http://bit.ly/d4woqQ
- I’m sure @GeneSherpas will be glad to see this. RT @23andMe, @KQEDScience: “23andMe Not Just for Fun Anymore” http://bit.ly/99WbVO
- “To Stop Crime, Share Your Genes” http://nyti.ms/ao3SDB NYT Op-Ed Argues for a national forensic DNA database.
- Obama Supports DNA Sampling Upon Arrest: http://bit.ly/cfg67K (Wired, v @cheriewoodward) Already occurring at FBI, appox 1/3 of states
- RT @mobilehealth: iPhone medical app the FDA took down: “We have never been involved in anything so peculiar…” http://tinyurl.com/ybl8tlo
- Willful ignorance is not an effective argument against personal genomics: http://bit.ly/cwc5J5 (by @dgmacarthur; well done)
- RT @dgmacarthur: RT @lukejostins: Very nice perspective on common-vs-rare variants and GWAS by p-ter over at GNXP http://bit.ly/aaMELy
- FDA Announces New Warning for Plavix linked to genotype http://bit.ly/9LdAVR (HT @GeneSherpas)
- RT @mikesgene: In a room full of geneticist / genetics related academic, gov’t & industry, only 4 have had a DTC genetic test. #genomics
- RT @dgmacarthur: RT @mikesgene: Geneticist Bob Church notes the bioethics we have been using for 25 years are now almost useless.
- Personalized Medicine, Genetic Testing and PBMs. Good top-level view from Bloomberg: http://bit.ly/bisRo3 (HT @westr)
- RT @BiotechPatent, @Xconomy Genetix Pharma Raises $35M from Third Rock, Genzyme for Gene Therapy http://bit.ly/9dd7dK
- Is this one for @phylogenomics’ worst ‘omics’ award? RT @FurnoX: Celebrogenomics – Illumina sequences Glenn Close http://ow.ly/1hbNS
- RT @chiah: “Transparent and open data does not equal USEFUL! (you have to build data visualization!)” @lostonroute66 #sxsh
- RT @NatureNews: Pharma to FDA: Let us keep tweeting, just w/ little logos & side links re safety & adverse effects. http://bit.ly/bgNmZW
Filed under: Uncategorized
